You bring up a 2007 article and entitle the post imminent buyout rumors. That is hilarious. JnJ had what about 450 million stent business and exited the bus. Abbott has better products. Bsx has recently paid 2 billion in patent infringements with more suits pending. So we have a laggard in the industry, with some nice debt and lawsuits pending and people are grasping at 2007 articles hoping to prop up the stock. The stock will bounce around some for sure, and they do have a chance to pick up some of the jnj business, jnj had 14% market share. Maybe bsx gets 100 million not enough to make a difference with 1.5 billion shares, and 4.5 billion in debt. Bsx has decent revenue, margins, but this will take time. No buyout on horizon until all the suits are done, and the debt is addressed.
Where did you "copy" "paste" your statements from. You're a friggin jerk just like the other idiots that say J&J will buy BSX out. What a imbecile you are. Try something original instead of plagerizing from the WSJ